Overfit deep neural network for predicting drug-target interactions
Xiao Xiaolin,
Liu Xiaozhi,
He Guoping,
Liu Hongwei,
Guo Jinkuo,
Bian Xiyun,
Tian Zhen,
Ma Xiaofang,
Li Yanxia,
Xue Na,
Zhang Chunyan,
Gao Rui,
Wang Kuan,
Zhang Cheng,
Wang Cuancuan,
Liu Mingyong,
Du Xinping
Affiliations
Xiao Xiaolin
Department of Cardiology, Tianjin Fifth Central Hospital, Tianjin, China; Tianjin Key Laboratory of Epigenetics for Organ Development of Premature Infants, Tianjin Fifth Central Hospital, Tianjin, China; Central Laboratory, Tianjin Fifth Central Hospital, Tianjin, China
Liu Xiaozhi
Tianjin Key Laboratory of Epigenetics for Organ Development of Premature Infants, Tianjin Fifth Central Hospital, Tianjin, China; Central Laboratory, Tianjin Fifth Central Hospital, Tianjin, China
He Guoping
Geriatrics Department, Traditional Chinese Medicine Hospital of Binhai New Area, Tianjin, China
Liu Hongwei
School of Clinical Medicine, North China University of Science and Technology, Tangshan, Hebei, China; Department of Anesthesiology, Tangshan Maternal and Child Health Hospital, Tangshan, Hebei, China
Guo Jinkuo
Tianjin Key Laboratory of Epigenetics for Organ Development of Premature Infants, Tianjin Fifth Central Hospital, Tianjin, China; College of Food Science and Engineering, Tianjin University of Science & Technology, Tianjin, China
Bian Xiyun
Tianjin Key Laboratory of Epigenetics for Organ Development of Premature Infants, Tianjin Fifth Central Hospital, Tianjin, China; Central Laboratory, Tianjin Fifth Central Hospital, Tianjin, China
Tian Zhen
Deepwater Technology Research Institute, China National Offshore Oil Corporation, Tianjin, China
Ma Xiaofang
Tianjin Key Laboratory of Epigenetics for Organ Development of Premature Infants, Tianjin Fifth Central Hospital, Tianjin, China; Central Laboratory, Tianjin Fifth Central Hospital, Tianjin, China
Li Yanxia
Tianjin Key Laboratory of Epigenetics for Organ Development of Premature Infants, Tianjin Fifth Central Hospital, Tianjin, China; Central Laboratory, Tianjin Fifth Central Hospital, Tianjin, China
Xue Na
Tianjin Key Laboratory of Epigenetics for Organ Development of Premature Infants, Tianjin Fifth Central Hospital, Tianjin, China; Central Laboratory, Tianjin Fifth Central Hospital, Tianjin, China
Zhang Chunyan
Tianjin Key Laboratory of Epigenetics for Organ Development of Premature Infants, Tianjin Fifth Central Hospital, Tianjin, China; Central Laboratory, Tianjin Fifth Central Hospital, Tianjin, China
Gao Rui
Tianjin Key Laboratory of Epigenetics for Organ Development of Premature Infants, Tianjin Fifth Central Hospital, Tianjin, China
Wang Kuan
Department of Cardiology, Tianjin Fifth Central Hospital, Tianjin, China
Zhang Cheng
Department of Cardiology, Tianjin Fifth Central Hospital, Tianjin, China
Wang Cuancuan
Department of Cardiology, Tianjin Fifth Central Hospital, Tianjin, China
Liu Mingyong
Tianjin Key Laboratory of Epigenetics for Organ Development of Premature Infants, Tianjin Fifth Central Hospital, Tianjin, China; Department of Urology, Tianjin Fifth Central Hospital, Tianjin, China
Du Xinping
Department of Cardiology, Tianjin Fifth Central Hospital, Tianjin, China; Tianjin Key Laboratory of Epigenetics for Organ Development of Premature Infants, Tianjin Fifth Central Hospital, Tianjin, China; College of Food Science and Engineering, Tianjin University of Science & Technology, Tianjin, China; Corresponding author
Summary: Drug-target interactions (DTIs) prediction is an important step in drug discovery. As traditional biological experiments or high-throughput screening are high cost and time-consuming, many deep learning models have been developed. Overfitting must be avoided when training deep learning models. We propose a simple framework, called OverfitDTI, for DTI prediction. In OverfitDTI, a deep neural network (DNN) model is overfit to sufficiently learn the features of the chemical space of drugs and the biological space of targets. The weights of trained DNN model form an implicit representation of the nonlinear relationship between drugs and targets. Performance of OverfitDTI on three public datasets showed that the overfit DNN models fit the nonlinear relationship with high accuracy. We identified fifteen compounds that interacted with TEK, a receptor tyrosine kinase contributing to vascular homeostasis, and the predicted AT9283 and dorsomorphin were experimentally demonstrated as inhibitors of TEK in human umbilical vein endothelial cells (HUVECs).